Connect with us
Anglostratits

Business

Merck Foundation calls for action together with 13 African First Ladies to Build Healthcare Capacity

Published

on

Merck

More than 10,000 participants attended the hybrid Luminary – onsite and online

DUBAI, United Arab Emirates, November 29, 2022/APO Group/ — 

Prof. Dr. Frank Stangenberg-Haverkamp, Senator Dr. Rasha Kelej and African First Ladies of Botswana, Burundi, Democratic Republic of Congo, The Gambia,  Ghana, Liberia, Malawi, Mozambique, Namibia, Sierra Leone, Angola and Central Africa Inaugurate 9th Edition of Merck Foundation (www.Merck-Foundation.com) Africa Asia Luminary 2022; African First Ladies marked together the 5th Anniversary of Merck Foundation and 10 year journey of their development programs  by sharing the impact of their partnership programs with Merck Foundation to build healthcare capacity, support girl education and break infertility stigma; More than 10,000 participants including healthcare providers, policymakers, researchers, academia and media representatives from 70 English, French, Spanish and Portuguese speaking countries attended the hybrid Luminary – onsite and online to benefit from scientific and social sessions to address social issues and advance healthcare capacity in 32 critical and underserved medical specialties.

Merck Foundation reported the impact of providing 1470 scholarships to doctors from 50 countries in 32 critical and underserved specialties such as; Oncology, Diabetes, Cardiovascular Preventive, Endocrinology, Fertility, Embryology, Reproductive Care, Respiratory Care, Acute and Intensive Care, Neonatal Care, Pediatric Emergency, Advanced Surgery, Microbiology & Infectious Diseases, Internal Medicine, Ophthalmology, Psychiatry, Palliative Care and Pain Management and more; Link to the Facebook live steam of Inaugural Session of Merck Foundation Africa Asia Luminary & African First Ladies High Level Panel: http://bit.ly/3XE4EWp

Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted their annual conference, the 9th Edition of “Merck Foundation Africa Asia Luminary” on 15th & 16th November 2022, as a hybrid conference (onsite and online). The conference was inaugurated by Prof. Dr. Frank Stangenberg-Haverkamp, Chairman of both of Executive Board of E.Merck KG and Merck Foundation Board of Trustees, and Senator, Dr. Rasha Kelej, CEO of Merck Foundation and Chairperson of Merck Foundation Africa Asia Luminary, along with African First Ladies of 13 Countries;

  • H.E. Mrs. NEO JANE MASISI, The First Lady of the Republic of Botswana
  • H.E. Madam ANGELINE NDAYISHIMIYE, The First Lady of the Republic of Burundi
  • H.E. Madam DENISE NYAKERU TSHISEKEDI, The First Lady of the Democratic Republic of The Congo
  • H.E. Mrs. FATOUMATTA BAH-BARROW, The First Lady of the Republic of The Gambia
  • H.E. Mrs. REBECCA AKUFO-ADDO, The First Lady of the Republic of Ghana
  • H.E. Mrs. CLAR MARIE WEAH, The First Lady of the Republic of Liberia
  • H.E. Mrs. MONICA CHAKWERA, The First Lady of the Republic of Malawi
  • H.E. Mrs. ISAURA FERRÃO NYUSI, The First Lady of the Republic of Mozambique
  • H.E. Mrs. MONICA GEINGOS, The First Lady of the Republic of Namibia
  • H.E. Dr. FATIMA MAADA BIO, The First Lady of the Republic of Sierra Leone
  • H.E. Mrs. MUTINTA HICHILEMA, The First Lady of the Republic of Zambia
  • H.E. Dr. ANA DIAS LOURENÇO, The First Lady of the Republic of Angola
  • H.E. Madam BRIGITTE TOUADERA, The First Lady of Central Africa

Merck Foundation CEO, Senator, Dr. Rasha Kelej emphasized, “I am very proud to welcome my dear sisters, our Guests of Honor and Keynote Speakersthe First Ladies of 13 African Countrieswho are also the Ambassadors of Merck Foundation “More Than a Mother”. We are together celebrating the 5th Anniversary of Merck Foundation and 10th Anniversary of our programs since 2012 which aim to build healthcare & media capacity and raise awareness on a wide range of sensitive and critical social and health issues like Supporting Girl Education, Ending Child Marriage, Stopping GBV, Breaking Infertility Stigma, Ending FGM, Women Empowerment, and Diabetes Awareness.

“I am proud that Merck Foundation has provided till today, more than 1470 scholarships to young doctors from 50 countries in 32 critical and underserved specialties. This is a great milestone of transforming patient care landscape and leading Africa to a better, healthier and stronger future. I am happy to hear from my dear sisters their experiences and success stories  in their respective countries, together we will be an important part of Africa’s legacy.” added Senator Kelej.

H.E. Mrs. NEO JANE MASISIThe First Lady of Botswana & Ambassador of Merck Foundation More Than A Mother said, ”Our partnership with Merck Foundation started in 2018 and since then, we have achieved very important milestones . Together with Merck Foundation, we launched a Poster Contest on “Stop GBV” initiative to end Gender-Based Violence in Botswana and Merck Foundation provided 20 Sewing Machines to the women groups who suffer GBV across Botswana to be able to generate monthly income. Moreover, more than 31 scholarships were provide for our local Doctors in Botswana in 32 different underserved and critical specialties such as: Diabetes, Endocrinology, Dermatology, Gastroenterology, Oncology, Respiratory Medicines, Acute Medicines and Sexual and Reproductive Medicines”.

H.E. Mrs. ANGELINE NDAYISHIMIYE, The First Lady of Burundi & Ambassador of Merck Foundation More Than A Mother stated, “I am very proud of the partnership we have with Merck Foundation. Through our long-term partnership, 47 scholarships have been provided for our local doctors in critical and underserved specialities such as Diabetes, Oncology, Fertility & Embryology, Sexual & Reproductive care, I am very happy to share that we have succeeded to establish the first public IVF center in Burundi and Merck Foundation has provided training for the staff of Fertility Specialists, Embryologists and also technicians, who are the first local experts in my country, we are making history in Burundi.”

H.E. Madam DENISE NYAKERU TSHISEKEDI, The First Lady of Democratic Republic of The Congo & Ambassador of Merck Foundation More Than A Mother said, “I would like to greatly acknowledge our valuable partnership with Merck Foundation that we started in 2020, and in a very short time, we have together achieved a lot. I am Proud to share that Merck Foundation have provided 77 scholarships to our doctors in the fields of Oncology, Fertility, Embryology, and Diabetes, which gave us our first Fertility specialists & Embryologists. Together, we also conducted the Online Health Media Training for our journalists to create a culture shift, to break the silence, and be the voice of the voiceless in order to raise awareness on sensitive social and health issues like Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM and Stopping GBV, Diabetes early detection and prevention”.

H.E. Mrs. FATOUMATTA BAH-BARROW, The First Lady of Republic of The Gambia & Ambassador of Merck Foundation More Than A Mother emphasized, “Our partnership journey is going from strength to strength as we have achieved many important and significant milestones since 2017, when I hosted Merck Foundation CEO and together, we launched the programs in my country. Through the partnership with Merck Foundation, 32 scholarships have been provided to young Gambian doctors in medical specialties. And, we are making history by providing training to first specialists in many fields such as Oncology, Respiratory, Fertility, Embryology, Reproductive Care, Diabetes, neonatal care, Endocrinology and more. It is history in the making.”

H.E. Mrs. REBECCA AKUFO-ADDO, The First Lady of Ghana & Ambassador of Merck Foundation More Than A Mother emphasized, “I have been working closely with Merck Foundation to empower women in general and infertile women in specific, not only through creating a culture shift but by also making the fertility, sexual and reproductive care available for them and their husbands whenever they need it, nationwide. We have been able to provide more than 110 scholarships of 32 specialty training in the fields of Cancer, Diabetes, Cardiology, Endocrinology, Respiratory, Acute Medicine, Sexual and Reproductive medicine, Embryology, Respiratory, Critical care, Psychiatry, General Surgery, Dermatology, Emergency and Resuscitation Medicine, Gastroenterology, Neuroimaging for Research, Pain Management, Rheumatology, and Neonatal Medicine. All these fields are very critical to our country which I consider a great milestone to transform patient care landscape in my country”.

H.E. Mrs. CLAR MARIE WEAH, The First Lady of Liberia & Ambassador of Merck Foundation More Than A Mother said, “I am very happy to work closely with Merck Foundation to empower infertile women through access to information, education, health and change of mindset. Merck Foundation also provided Sanitary Napkin Production Machine and raw materials, this will really help our young girls. I truly appreciate our partnership and acknowledge their smart and serious strategy to provide specialty training for our local doctors. Till today, 37 scholarships have been provided to our doctors in many critical and underserved specialties. This is a huge achievement for us, and we are definitely making history in Libera by training the first specialists in many medical fields such as: Infertility, Embryology, Oncology and Diabetes”.

H.E. Mrs. MONICA CHAKWERA, The First Lady of Malawi & Ambassador of Merck Foundation More Than A Mother expressed, “I have worked closely with Merck Foundation since 2020 to define the right strategy to build healthcare capacity, empower infertile women, and support girl education in Malawi. With the support of Merck Foundation and their “Empowering Berna” program , 13 women have transformed their lives as they got a chance to establish their own small businesses so that they can be financially independent; and under the ‘Educating Linda’ program, we provided scholarships of 60 Malwian school girls to continue thier education till they graduate. Moreover, 33 scholarships have been provided to young Malawian doctors in 32 critical medical specialties such as Fertility & Embryology, Diabetes, Endocrinology, Oncology, Internal Medicine, Sexual & Reproductive Medicines, Ousmane emergency, respiratory care, acute care and more. My journey with Merck Foundation has definitely been amazing, very impactful and efficient”.

H.E. Mrs. ISAURA FERRÃO NYUSI, The First Lady of Mozambique & Ambassador of Merck Foundation More Than A Mother emphasized, “I am very impressed with initiatives of Merck Foundation under the “More Than a Mother” Campaign. We recently conducted our First Online Health Media Training for our journalists to emphasize on the important role that media plays to influence our society to raise awareness on a wide range of social and health issues. The training session benefitted many of our journalists. Together with Merck Foundation, I am fully committed to working closely to introduce more such innovative ideas that engage different sectors to create a culture shift. Moreover, 14 scholarships have been provided to our doctors for the Online Diabetes Master course, a unique course specially developes in Portuguese language so that our local doctors can benefit from it, under Merck Foundation’s  Nationwide Diabetes Blue Points Program”.

H.E. Mrs. MONICA GEINGOS, The First Lady of Namibia & Ambassador of Merck Foundation More Than A Mother said “I am glad to have this ongoing long-term beneficial partnership with Merck Foundation. I am particularly excited as Merck More Than a Mother Ambassador, as together we have been doing amazing work in the country to empower women living with infertility through access to information, education, information, change of mindset and economic empowerement. Moreover, 53 scholarships have been provided to young Namibian doctors in the fields of Diabetes, Cardiology, Endocrinology, Respiratory Medicines, Acute Medicines and Sexual and Reproductive Medicines, and many more. For Namibia, 2.4M population, we will soon have more than 18 skilled and trained doctors nationwide  to assist couples living with infertility or need any sexual & reproductive help, this will be a significant contribution towards improving women health in general and reproductive health in specific”.

I am proud that Merck Foundation has provided till today, more than 1470 scholarships to young doctors from 50 countries in 32 critical and underserved specialties

H.E. Dr. FATIMA MAADA BIO, The First Lady of the Republic of Sierra Leone stated, “Our partnership with Merck Foundation is since 2018 and we highly appreciate their programs. Together, we have provided 46 scholarships to our doctors from different provinces of Sierra Leone in the fields of Oncology, Embryology & Fertility, Sexual and Reproductive Health Medicine, Diabetes, Endocrinology, Orthopaedics, Clinical Microbiology & Infectious Diseases, Clinical Psychiatry, Dermatology, Gastroenterology, Internal Medicine, Neonatal Medicine, Paediatric Emergency Medicine, Cardiovascular Medicine, Respiratory Medicine and Emergency and Resuscitation Medicine. I can proudly say that along with Merck Foundation we are making history in Sierra Leone by providing training for the First Oncologists in the country with the aim to establish the first skilled cancer care team who will be working in our new hospital, this will improve access to quality and equitable cancer care in the country. This is a huge achievement for us since we did not have any oncologists or fertility specialists and we have in general a very limited number of local specialists in the public sector before starting our partnership with Merck Foundation.”

H.E. Mrs. MUTINTA HICHILEMA, The First Lady of the Republic of Zambia expressed, “I am very proud of our partnership with Merck Foundation. I am very impressed with ‘Educating Linda’ program to support girl education and provide scholarships to girls to complete thier education by providing thier tutiton fees, we have implememted this program in Zambia and provided 22 girls with scholarships to cover thier tuttion fees of nursing schools and health sciences univesities .this scholarship wil continue till they complete thier education successfully. I also very interested in “More Than a Mother” Campaign, this campaign is very critical for my country and Africa, at large. I am fully supporting this initiative as the First Lady of Zambia and as an african woman, it is very close to my heart. Moreover, together with Merck Foundation, we have provided 50 scholarships to our doctors from different provinces across Zambia and we will scale up this program under the leadership of my office”.

During her speech, H.E. Mrs. ANA DIAS LOURENÇOThe First Lady of the Republic of Angola & Ambassador of Merck Foundation More Than A Mother stated, “I am looking forward to start the implementation of the ‘Educating Linda’ Program which aims to empower girls through education and end child marriage, this program is very close to my heart as I consider it one of my main objectives as the First Lady of Angola; and as an African woman, I strongly believe that girl Education is one of the most critical areas of women empowerment. Moreover, I am very excited about the 8 important different competitions for our communities which are: Best Media, Song, Film and Fashion awards with the aim to encourage Media, Musicians, Fashion Designers, Filmmakers, students, and new potential talents in these fields to play their important role in sensitizing their communities about many critical social and health issues.”

H.E. Madam BRIGITTE TOUADERA, The First Lady of Central Africa & Ambassador of Merck Foundation More Than A Mother emphasized “I greatly value our partnership with Merck Foundation that is since 2015, to support us to advance and build the healthcare capacity in our country by providing scholarships to our local doctors in various medical specialities. Together, we worked on “Empowering Berna” program where we established small businesses for infertile and childless women and trained them to run their businesses so they can have income and become independent and have purpose life. Also, as a part of Merck Foundation’s Education Linda program, we will be providing scholarships to 20 under-privileged schoolgirls from our country to support girl education. Moreover, 5 scholarships have been provided to our doctors by Merck Foundation so far in Oncology and Diabetes”.

The 9th Edition of Merck Foundation Africa Asia Luminary 2022 was streamed live on the social media handles of Merck Foundation (http://bit.ly/32YFKpv) and Senator, Dr. Rasha Kelej(http://bit.ly/3ATPaEd).

Link to the Facebook live steam of Inaugural Session of Merck Foundation Africa Asia Luminary & African First Ladies High Level Panel: (https://bit.ly/3XE4EWp)

Merck Foundation is transforming the Patient care landscape and making history together with its partners in Africa, Asia, and beyond, through:

• 1470 + Scholarships provided by Merck Foundation for doctors from 50 Countries in 32 critical and underserved medical specialties.  

Merck Foundation is also creating a culture shift and breaking the silence about a wide range of social and health issues in Africa and underserved communities through:

• 2200 + Media Persons from more than 50 countries trained to better raise Awareness about different social and health issues

• 8 Different Awards Launched annually for best media coverage, fashion designers, films, and songs

• Around 30 songs to address health and social issues by local singers across Africa

• 8 Children’s Storybooks in three languages – English, French, and Portuguese

• Pan African TV Program “Our Africa by Merck Foundation” TV Program addressing Social and Health Issues in Africa through “Fashion and ART with Purpose” Community

• 1000+ Girls from 15 African countries supported through scholarships or school items, annually.

• 9 Social Media Channels with more than 5 Million Followers

Distributed by APO Group on behalf of Merck Foundation.

Business

Africa’s Lithium Pipeline Gains Momentum as Global Supply Deficits Loom

Published

on

Energy Capital

The upcoming African Mining Week 2026 – taking place from October 14-16 in Cape Town – will connect global investors with prospects within the lithium industry amidst an anticipated resource supply deficit by 2028

CAPE TOWN, South Africa, April 9, 2026/APO Group/ –Rising demand for lithium is positioning Africa to attract foreign investment, accelerate local beneficiation and strengthen its role in securing the global battery supply chain. A recent forecast by Wood Mackenzie projects that global lithium demand could exceed 13 million tons by 2050 under an accelerated energy transition scenario. This surge is expected to place significant pressure on supply, with deficits emerging as early as 2028. Without substantial new investments, existing lithium projects will struggle to meet demand beyond the mid-2030s.

 

Against this backdrop, Africa’s growing pipeline of greenfield and development-stage lithium projects positions the continent as an increasingly important contributor to global supply security. In 2025, Africa ranked as the largest source of new lithium supply globally, with new output from the region exceeding that of the rest of the world combined. This milestone underscores the continent’s potential to scale production and strengthen its role in the global battery minerals market.

Emerging Lithium Producers Strengthen Africa’s Supply Pipeline

Even under a slower energy transition scenario, Wood Mackenzie projects that lithium markets will remain adequately supplied until 2037, before entering deficit. This outlook reinforces Africa’s strategic role as new projects across Mali, Zimbabwe, Ghana and Namibia advance toward production.

In the Democratic Republic of the Congo (DRC), Zijin Mining, AVZ Minerals and KoBold Metals are expected to begin operations at the Manono lithium project in mid-to-late 2026, marking the country’s first lithium output. Ranked among the world’s largest hard-rock lithium deposits, Manono is expected to begin exports shortly after commissioning, diversifying DRC’s mineral output while strengthening the continent`s contribution to the global electric vehicles and battery supply chain.

Mali Emerges as a Regional Lithium Hub

Mali is also rapidly positioning itself as a key lithium producer. The Bougouni Lithium Project, commissioned in 2025, currently produces approximately 125,000 tons per annum of concentrate, with Phase Two expansion plans underway that could nearly double production capacity.

Meanwhile, the Goulamina Lithium Project, one of the largest spodumene deposits globally, is producing around 506,000 tons of spodumene concentrate annually, with expansion plans targeting one million tons per year. Together, these projects are expected to significantly strengthen Mali and Africa’s position within the global lithium market.

Ghana and Zimbabwe Expand Lithium Production and Value Addition

In Ghana, the Ewoyaa Lithium Project, developed by Atlantic Lithium, is set to become the country’s first lithium-producing mine, with production targeted for late 2027. The project is expected to produce 3.58 million tons of spodumene concentrate grading 6% and 5.5%, alongside approximately 4.7 million tons of secondary product, further strengthening Africa’s contribution to global lithium supply.

Meanwhile, Zimbabwe – currently Africa’s largest lithium producer – is accelerating efforts to move up the value chain. Government policies restricting the export of raw lithium are encouraging investment in local processing and beneficiation facilities, supporting the production of higher-value lithium products and positioning the country as a key supplier to the global battery materials market.

Investment Momentum Builds Ahead of African Mining Week

With an estimated $276 billion in new investment required to avoid the forecast supply deficits beginning in 2028, Africa’s lithium-rich countries are well positioned to attract the capital needed to expand production and downstream processing.

In this context, African Mining Week 2026 – scheduled for October 14–16 in Cape Town – will serve as a key platform for global investors, project developers and policymakers to engage on opportunities within Africa’s lithium sector. As the continent’s premier mining investment event, the conference will feature high-level discussions, project showcases and strategic networking sessions aimed at accelerating partnerships across the lithium value chain.

Distributed by APO Group on behalf of Energy Capital & Power.

Continue Reading

Business

Afreximbank delivers strong FY2025 results; with a total assets and contingencies base of US$48.5 billion

Published

on

Afreximbank

Total assets and contingencies rose by 21% to US$48.5 billion, up from US$40.1 billion as at 31 December 2024, underscoring the Bank’s consistent growth trajectory

The Group’s balance sheet is at its strongest level ever, with liquidity levels and capitalisation well above target and good asset quality

CAIRO, Egypt, April 9, 2026/APO Group/ –African Export-Import Bank (“Afreximbank” or the “Bank”) (www.Afreximbank.com) and its subsidiaries (the “Group”) has announced strong results for the year ended 31 December 2025, underscoring sustained financial resilience, increased market confidence and strategic execution.

 

Total assets and contingencies rose by 21% to US$48.5 billion, up from US$40.1 billion as at 31 December 2024, underscoring the Bank’s consistent growth trajectory.

Net loans and advances for the Group closed the year at US$33.5 billion (FY’2024: US$29.0 billion), an increase of 16%, supported by continued disbursements across the continent and the Caribbean through various product offerings. The Group funded strategic priorities areas such as manufacturing, infrastructure, food security and climate adaptation.

The Group’s non-performing loan (NPL) ratio remained stable at 2.43% (FY’2024: 2.33%), demonstrating consistent portfolio quality.

The Group’s liquidity position remained robust, with cash and cash equivalents at US$6.0 billion (FY’2024: US$4.6 billion). Liquid assets accounted for 14% of total assets, above the Bank’s strategic minimum level of 10%. Shareholders’ funds grew by 17% to US$8.4 billion as at 31 December 2025, driven by net income of US$1.2 billion, and new equity inflows of US$299.4 million raised under the General Capital Increase II.

Gross Income increased by 6.06% reaching US$3.5 billion in FY’2025 from US$3.3 billion achieved in FY’2024.

Operating expenses increased to US$459.2 million (FY’2024: US$367.7 million), reflecting strategic staff expansion, and inflationary pressures with the Group maintained strong cost efficiency resulting in a cost-to-income ratio of 21% (FY’2024: 18%) well below the strategic ceiling of 30%.

Contrary to concerns raised by some rating agencies during the year, the Bank accessed international bond markets by successfully raising over US$800 million from Japan and China, courtesy of the Samurai and Panda bonds in 2025. This demonstrated the Group’s fund-raising capabilities and the solid nature of the Bank’s DNA as a pan-African multilateral financial institution committed to ensuring that Africa’s full and sustainable self-reliance remain firm.

Net income increased by 19% to US$1.2 billion in 2025, up from US$973.5 million in the prior year. These results were achieved through the expanded delivery of tailored financial and advisory solutions that supported trade, fostered industrialisation and enhanced economic self-reliance.

Highlights of the results for Afreximbank Group are shown below:

Financial Performance Metrics

FY’2025

FY’2024

Gross Income (US$ billion)

3.5

3.3

Net Income (US$ million)

1,156.8

973.5

Return on average equity (ROAE)

15%

15%

Return on average assets (ROAA)

3.04%

2.96%

Cost-to-income ratio

21%

18%

 

Financial Position Metrics

FY’2025

9M’2024

Total Assets (US$ billion)

42.3

35.3

Total Liabilities (US$ billion)

33.9

28.1

Shareholders’ Funds (US$ billion)

8.4

7.2

Non-performing loans ratio (NPL)

  2.43%

2.33%

Cash/Total assets

14%

13%

Capital Adequacy ratio (Basel II)                                                                         23%

24%

 

Mr. Denys Denya, Afreximbank’s Senior Executive Vice President, commented:

 

“Despite continuing global geopolitical challenges and disruptions caused by some rating actions, the Group delivered excellent financial performance in 2025, a fitting tribute to a decade of consequential leadership under Professor Oramah, with total assets and contingencies reaching $49 billion. Pleasingly, the Group is way ahead on most of it targets in delivery on its 6th Strategic plan that ends on 31 December 2026. With recently established subsidiaries such as FEDA and AfrexInsure becoming profitable, Net income grew by 19% to stand at US$1.2 billion, underpinned by a strong capital base of US$8.4 billion. The Group’s balance sheet is at its strongest level ever, with liquidity levels and capitalisation well above target and good asset quality. These results are a testament to the unwavering execution by the Group’s hard working human capital. We entered 2026 financial year with significant momentum, ready to scale the Group’s impact, accelerate trade integration and value addition across Global Africa, and deliver greater value to our shareholders.”

Distributed by APO Group on behalf of Afreximbank.

Continue Reading

Events

Chinese Mainland’s Largest Conference on Chest Pain Centres Goes Global in Hong Kong

Published

on

Hong Kong

With robust lineup of medical conventions in 2026

HONG KONG SAR – Media OutReach Newswire – 9 April 2026 – Marking yet another milestone as the World’s Meeting Place, Hong Kong became the first city outside Chinese Mainland to host the nation’s largest conference on chest pain centres – the 15th China Chest Pain Centers Congress (CCPCC 2026), thanks to the effort of Hong Kong Convention Ambassador (HKCA) appointed by the Hong Kong Tourism Board (HKTB).
Together with two other high-profile and hugely successful medical congresses – the 41st Asia Pacific Academy of Ophthalmology Congress in February and the 17th Asian Congress of Oral & Maxillofacial Surgery in March, Hong Kong’s medical science events space was off to a strong start in 2026.

Ms Marilyn Tham, General Manager of Mega Events, MICE & Cruise of the HKTB said, “Hong Kong’s leading edge in medical sciences coupled with the city’s world-class venues and destination appeal have enabled notable success for internationally significant medical events. CCPCC 2026 is one of the large-scale medical conventions confirmed for 2026. Such robust lineup reflects event organisers’ confidence in Hong Kong as a premier hub for advancing global exchanges on medical sciences.”

Over 10 medical conventions have secured a spot in Hong Kong this year, spanning diverse disciplines, from cytology to oncology, antimicrobial resistance and more (see full list below). The breadth and depth of the events reflects Hong Kong’s growing appeal as the premier convention hub where global medical minds meet.

Globalising Chest Pain Leadership from Hong Kong

Held on 3-4 April 2026 at the Hong Kong Convention and Exhibition Centre with a concurrent venue in Shenzhen, CCPCC 2026 converged 3,000 healthcare leaders, physicians, nurses, researchers, policymakers and industry experts from Hong Kong, Chinese Mainland, the Belt and Road countries and beyond. The rich topics explored across two days encompassed cutting-edge healthcare innovations, AI-assisted clinical decision-making, intelligent emergency response systems and international accreditation standards.

Co-organised by Hospital Authority (HA) of Hong Kong, the National Clinical Research Center for Interventional Medicine, the Guangdong Chest Pain Centers Association, the Chinese Cardiovascular Association (CCA) and Oriental Huaxia Cardiovascular Health Research Institute (OHCHRI), Suzhou Industrial Park, CCPCC 2026 showcased conducive partnership.

Mr. Wenming Zeng, Secretary-General of OHCHRI, remarked, “The global influence of CCPCC has been growing over the years. Thanks to Hong Kong’s strategic location, leading medical standing and its unique role bridging Chinese Mainland and the world, this year’s congress has drawn even wider global participation, giving the event greater international significance. Hong Kong has helped showcase our event to the world, taking cardiovascular emergency intervention to a new height globally.”

A Launchpad for Mainland-spearheaded International Standards

Capitalising on Hong Kong’s strengths as a super-connector for fostering globalisation, CCPCC 2026 released for the first time the “International Standards on Chest Pain Center Construction and Accreditation”, marking Mainland’s global leadership in cutting-edge cardiovascular emergency intervention. Leveraging Hong Kong’s internationalisation, the efforts to foster global policy support and implementation of the standards will contribute to fair, accessible and timely intervention for cardiovascular emergencies around the world.

Another Significant Win for HKCA Programme on its 5th Anniversary

As a HKTB-appointed HKCA, Prof Lu Shi-Juan, who is a Member of Hainan Medical Association Cardiovascular Professional Committee, played an instrumental role in bringing CCPCC 2026 to Hong Kong. This marked the latest success story of the HKCA programme, as HKTB celebrated the programme’s milestone 5th anniversary with a HKCA Networking Cocktail Event on 31 March, 2026.

Prof Lu noted, “As a Hong Kong International Convention Ambassador, I have worked closely with the HKTB to bring CCPCC to Hong Kong, which is a gateway to the global stage. Hosting the conference here showcases how Hong Kong can elevate Mainland conferences internationally, foster cross‑border knowledge exchange and help shape the future development of the broader medical and professional community.”
The HKCA programme bands together over 170 local and mainland sector leaders of 13 industries and academics to champion Hong Kong as the World’s Meeting Place. Their initiative and connections have helped Hong Kong secure 50 convention wins that have brought in nearly 100,000 high-value overnight MICE visitors.

Strong Medical Events Lineup in 2026

Over 10 medical conventions will be held in 2026 across various disciplines, including ophthalmology, oncology, antimicrobial resistance and cytology.

Event

(*first-ever in Hong Kong)

Date / Venue Highlights
The 41st Asia-Pacific Academy of Ophthalmology Congress 2026 5-8 Feb,

HKCEC

The largest and most authoritative ophthalmology congress in APAC, returning to HK for the fifth time, with record-breakingattendance of 11,000+ participants from 111 countries and regions.
The 17th Asian Congress on Oral and Maxillofacial Surgery 2026 27-29 Mar,

HKCEC

Held in Hong Kong for the second time, bringing together internationally acclaimed speakers, globally renowned experts and young surgeons to foster academic exchange and professional development.
The 15th China Chest Pain Centers Congress 3-4 Apr,

HKCEC

Chinese Mainland’s largest conference on chest pain centres, hosted for the first time outside Chinese Mainland.
*Asian Federation of Cytology Societies Conference 2026 8-10 May,

Postgraduate Education Centre, Prince of Wales Hospital

First edition in Hong Kong, bringing together regional and international cytology experts for academic exchange and collaboration.
International Symposium on Antimicrobial Agents and Resistance 2026 12-14 Jun,

HKCEC

A key international platform for academic exchange on infectious diseases and antimicrobial resistance.
European Society of Medical Oncology Targeted Anticancer Therapies Asia 2026 12-14 Jun,

Kerry Hotel

A key Asia-Pacific platform for showcasing the latest advances in early-phase oncology drug development, targeted therapies and precision oncology.
Federation of Asian and Oceanian Biochemists and Molecular Biologists Conference 2026 10-13 Aug,

Cheung Kung Hai Conference Centre, The University of Hong Kong

A major regional scientific meeting in biochemistry and molecular biology, bringing together researchers, educators and professionals from across Asia and Oceania for academic exchange and collaboration.
* 2026 World Cancer Congress 24-26 Sep,

HKCEC

A leading global forum advancing cancer control and research.
2026 Asia-Pacific Longevity Medicine International Summit 1-4 Oct,

TBC

A leading international platform and regional collaborative hub dedicated to longevity medicine and innovation, attracting top longevity scientists, medical experts, cross-industry entrepreneurs and investors from over 50 countries.
10th Asia Cornea Society Scientific Meeting 2026 11-13 Dec,

TBC

A key regional forum for cornea specialists to exchange the latest clinical insights, diagnostics and treatments, and to strengthen collaboration across the Asia-Pacific ophthalmology community.
Association of Pacific Rim Universities (APRU) Global Health Conference 2026 7-9 Dec,

Henry Cheng International Conference Centre, CUHK

Third time in Hong Kong, convening leading academics, policymakers and practitioners to address critical global health challenges through interdisciplinary collaboration and innovation.

 

Continue Reading

Trending